Table of Contents
List of Tables
List of Figures
NovoCure Ltd Company Overview
NovoCure Ltd Company Snapshot
NovoCure Ltd Pipeline Products and Ongoing Clinical Trials Overview
NovoCure Ltd – Pipeline Analysis Overview
Business Description
NovoCure Ltd – Key Facts
NovoCure Ltd – Major Products and Services
NovoCure Ltd Pipeline Products by Development Stage
NovoCure Ltd Ongoing Clinical Trials by Trial Status
NovoCure Ltd Pipeline Products Overview
MAXPOINT Treatment Planning Software
MAXPOINT Treatment Planning Software Product Overview
NovoTTF-200A – Small Cell Lung Cancer
NovoTTF-200A – Small Cell Lung Cancer Product Overview
Optune – Brain Metastasis
Optune – Brain Metastasis Product Overview
Optune – Brain Metastasis Clinical Trial
Optune – Breast Cancer
Optune – Breast Cancer Product Overview
Optune – Cervical Cancer
Optune – Cervical Cancer Product Overview
Optune – Colorectal Carcinoma
Optune – Colorectal Carcinoma Product Overview
Optune – Ependymoma
Optune – Ependymoma Product Overview
Optune – Gastric Adenocarcinoma
Optune – Gastric Adenocarcinoma Product Overview
Optune – Gastric Adenocarcinoma Clinical Trial
Optune – Gliosarcoma
Optune – Gliosarcoma Product Overview
Optune – Liver Cancer
Optune – Liver Cancer Product Overview
Optune – Malignant Melanoma
Optune – Malignant Melanoma Product Overview
Optune – Medulloblastoma
Optune – Medulloblastoma Product Overview
Optune – Meningioma
Optune – Meningioma Product Overview
Optune – Mesothelioma
Optune – Mesothelioma Product Overview
Optune – Non – Small Cell Lung Cancer
Optune – Non – Small Cell Lung Cancer Product Overview
Optune – Non – Small Cell Lung Cancer Clinical Trial
Optune – Ovarian Cancer
Optune – Ovarian Cancer Product Overview
Optune – Ovarian Cancer Clinical Trial
Optune – Pancreatic Cancer
Optune – Pancreatic Cancer Product Overview
Optune – Pancreatic Cancer Clinical Trial
Optune – Pediatric Glioma
Optune – Pediatric Glioma Product Overview
Optune – Pediatric Glioma Clinical Trial
Optune – Renal Adenocarcinoma
Optune – Renal Adenocarcinoma Product Overview
Optune – Small Cell Lung Cancer
Optune – Small Cell Lung Cancer Product Overview
Optune – Urinary Transitional Cell Carcinoma
Optune – Urinary Transitional Cell Carcinoma Product Overview
Optune Plus Bevacizumab – Recurrent Glioblastoma
Optune Plus Bevacizumab – Recurrent Glioblastoma Product Overview
Optune Plus Bevacizumab – Recurrent Glioblastoma Clinical Trial
Optune With Marizomib And Temozolomide – Glioblastoma
Optune With Marizomib And Temozolomide – Glioblastoma Product Overview
Optune With Marizomib And Temozolomide – Glioblastoma Clinical Trial
NovoCure Ltd – Key Competitors
NovoCure Ltd – Key Employees
NovoCure Ltd – Key Employee Biographies
NovoCure Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
NovoCure Ltd, Recent Developments
Nov 10, 2020: Novocure announces agenda for Virtual Research and Development Day
Oct 29, 2020: Novocure announces strategic alliance with NYU Grossman School of Medicine for preclinical and clinical Research
Jul 28, 2020: Novocure announces recipients of 2nd Annual AACR-Novocure grants for tumor treating fields research program
Mar 12, 2020: Preclinical data show tumor treating fields induces immunogenic cell death resulting in enhanced antitumor efficacy when combined with Anti-PD-1 therapy
Feb 27, 2020: Novocure reports fourth quarter and full year 2019 financial results and provides company update
Feb 11, 2020: Mesothelioma treatment center offers new at-home device
Jan 21, 2020: Novocure announces national reimbursement in Israel for Optune in combination with temozolomide for the treatment of newly diagnosed glioblastoma
Jan 13, 2020: Novocure announces fourth quarter and full year 2019 preliminary net revenues and provides company update
Jan 09, 2020: Zai Lab and Novocure announce first patient enrolled in a phase 2 pilot trial of tumor treating fields together with chemotherapy as first-line treatment of gastric cancer
Oct 31, 2019: Novocure reports third quarter 2019 financial results and provides company update
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
NovoCure Ltd Pipeline Products and Ongoing Clinical Trials Overview
NovoCure Ltd Pipeline Products by Equipment Type
NovoCure Ltd Pipeline Products by Indication
NovoCure Ltd Ongoing Clinical Trials by Trial Status
NovoCure Ltd, Key Facts
NovoCure Ltd, Major Products and Services
NovoCure Ltd Number of Pipeline Products by Development Stage
NovoCure Ltd Pipeline Products Summary by Development Stage
NovoCure Ltd Ongoing Clinical Trials by Trial Status
NovoCure Ltd Ongoing Clinical Trials Summary
MAXPOINT Treatment Planning Software - Product Status
MAXPOINT Treatment Planning Software - Product Description
NovoTTF-200A - Small Cell Lung Cancer - Product Status
NovoTTF-200A - Small Cell Lung Cancer - Product Description
Optune - Brain Metastasis - Product Status
Optune - Brain Metastasis - Product Description
Optune - Brain Metastasis - A Phase II Randomized Study of TTField Therapy (150 kHz) Versus Supportive Care in Non-small Cell Lung Cancer Patients with 1-5 Brain Metastases Following Optimal Standard Local Treatment
Optune - Brain Metastasis - Phase II Study of Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma with Brain Metastasis
Optune - Brain Metastasis - Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Optune - Brain Metastasis - Prophylactic Tumor Treating Fields in Management of Patients with Small Cell Lung Cancer
Optune - Breast Cancer - Product Status
Optune - Breast Cancer - Product Description
Optune - Cervical Cancer - Product Status
Optune - Cervical Cancer - Product Description
Optune - Colorectal Carcinoma - Product Status
Optune - Colorectal Carcinoma - Product Description
Optune - Ependymoma - Product Status
Optune - Ependymoma - Product Description
Optune - Gastric Adenocarcinoma - Product Status
Optune - Gastric Adenocarcinoma - Product Description
Optune - Gastric Adenocarcinoma - A Phase II Pilot Study of Tumor Treating Fields Together with Chemotherapy as First-line Treatment of Gastric Cancer
Optune - Gliosarcoma - Product Status
Optune - Gliosarcoma - Product Description
Optune - Liver Cancer - Product Status
Optune - Liver Cancer - Product Description
Optune - Malignant Melanoma - Product Status
Optune - Malignant Melanoma - Product Description
Optune - Medulloblastoma - Product Status
Optune - Medulloblastoma - Product Description
Optune - Meningioma - Product Status
Optune - Meningioma - Product Description
Optune - Mesothelioma - Product Status
Optune - Mesothelioma - Product Description
Optune - Non - Small Cell Lung Cancer - Product Status
Optune - Non - Small Cell Lung Cancer - Product Description
Optune - Non - Small Cell Lung Cancer - Prophylactic Tumor Treating Fields in Management of Patients with Small Cell Lung Cancer
Optune - Non - Small Cell Lung Cancer - Study Evaluating the Safety and Efficacy of Tumor Treating Fields Together with KEYTRUDA (pembrolizumab) in Subjects with Non-small Cell Lung Cancer
Optune - Ovarian Cancer - Product Status
Optune - Ovarian Cancer - Product Description
Optune - Ovarian Cancer - An Open Label Pilot Study of the NovoTTF-100L(O) System (NovoTTF Therapy) (200 kHz) Concomitant with Weekly Paclitaxel for Recurrent Ovarian Carcinoma
Optune - Ovarian Cancer - Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer: ENGOT-ov50 / GOG-3029 / INNOVATE-3
Optune - Pancreatic Cancer - Product Status
Optune - Pancreatic Cancer - Product Description
Optune - Pancreatic Cancer - Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Optune - Pediatric Glioma - Product Status
Optune - Pediatric Glioma - Product Description
Optune - Pediatric Glioma - A Phase I Trial of the Optune NovoTTF-200A System with Concomitant Temozolomide and Bevacizumab in Pediatric Patients with High-grade Glioma (HUMC 1612)
Optune - Pediatric Glioma - Feasibility Trial of Optune for Children with Recurrent or Progressive Supratentorial High-grade Glioma and Ependymoma
Optune - Renal Adenocarcinoma - Product Status
Optune - Renal Adenocarcinoma - Product Description
Optune - Small Cell Lung Cancer - Product Status
Optune - Small Cell Lung Cancer - Product Description
Optune - Urinary Transitional Cell Carcinoma - Product Status
Optune - Urinary Transitional Cell Carcinoma - Product Description
Optune Plus Bevacizumab - Recurrent Glioblastoma - Product Status
Optune Plus Bevacizumab - Recurrent Glioblastoma - Product Description
Optune Plus Bevacizumab - Recurrent Glioblastoma - A Phase II Trial of Tumor Treating Fields (TTfields) Concomitant with Radiosurgery for the Treatment of Recurrent, Bevacizumab-naïve Glioblastoma
Optune With Marizomib And Temozolomide - Glioblastoma - Product Status
Optune With Marizomib And Temozolomide - Glioblastoma - Product Description
Optune With Marizomib And Temozolomide - Glioblastoma - Phase 1B, Multicenter, Open-label Study of Marizomib Combined with Temozolomide and Radiotherapy in Patients with Newly Diagnosed who Grade IV Malignant Glioma
NovoCure Ltd, Key Employees
NovoCure Ltd, Key Employee Biographies
NovoCure Ltd, Subsidiaries
Glossary